+ All Categories
Home > Documents > Cardiogenic_Shock.ppt

Cardiogenic_Shock.ppt

Date post: 09-Oct-2015
Category:
Upload: igor-stefanet
View: 7 times
Download: 0 times
Share this document with a friend
Popular Tags:

of 27

Transcript
  • 5/19/2018 Cardiogenic_Shock.ppt

    1/27

    Cardiogenic Shock andHemodynamics

  • 5/19/2018 Cardiogenic_Shock.ppt

    2/27

    Outline

    Overview of shock

    Hemodynamic Parameters

    PA catheter, complications

    Differentiating Types of Shock

    Cardiogenic Shock

    Etiologies

    Pathophysiology

    Clinical Findings

    Treatment

  • 5/19/2018 Cardiogenic_Shock.ppt

    3/27

    SHOCK= Inadequate Tissue Perfusion

    Mechanisms: Inadequate oxygen delivery

    Release of inflammatory mediators

    Further microvascular changes, compromisedblood flow and further cellular hypoperfusion

    Clinical Manifestations: Multiple organ failure

    Hypotension

  • 5/19/2018 Cardiogenic_Shock.ppt

    4/27

    Hemodynamic Parameters

    Systemic Vascular Resistance (SVR)

    Cardiac Output (CO) Mixed Venous Oxygen Saturation (SvO2)

    Pulmonary Capillary Wedge Pressure

    (PCWP)

    Central Venous Pressure (CVP)

  • 5/19/2018 Cardiogenic_Shock.ppt

    5/27

    Normal Values

    Right Atrial

    Pressure, CVP

    Mean 0-6mmHg

    Pulmonary

    Artery Pressure

    Systolic

    End-diastolic

    mean

    15-30mmHg

    4-12mmHg

    9-19mmHg

    PCWP Mean 4-12mmHgCardiac Output 4-8 L/min

    Mixed Venous

    O2 Sat

    >70%

    SVR 800-1200

  • 5/19/2018 Cardiogenic_Shock.ppt

    6/27

    Differentiating Types of Shock

  • 5/19/2018 Cardiogenic_Shock.ppt

    7/27

    PA Catheter Complications

    Path of PAC: central venous circulation R

    heart pulmonary artery. The proximal port is in

    R atrium, distal port in pulm artery

    Arrhythmias

    RBBB

    PA rupture

    PAC related infection

    Pulmonary infarction

  • 5/19/2018 Cardiogenic_Shock.ppt

    8/27

    Cardiogenic Shock

    Systemic hypoperfusion secondary to

    severe depression of cardiac output andsustained systolic arterial hypotension

    despite elevated filling pressures.

  • 5/19/2018 Cardiogenic_Shock.ppt

    9/27

    Cardiogenic Shock

    Etiologies

    Pathophysiology Clinical/Hemodynamic Characteristics

    Treatment Options

  • 5/19/2018 Cardiogenic_Shock.ppt

    10/27

    Etiologies

    Acute myocardialinfarction/ischemia

    LV failure

    VSR

    Papillary muscle/chordalrupture- severe MR

    Ventricular free wallrupture with subacute

    tamponade

    Other conditions complicating largeMIs

    Hemorrhage

    Infection

    Excess negative inotropic orvasodilator medications

    Prior valvular heart disease

    Hyperglycemia/ketoacidosis

    Post-cardiac arrest

    Post-cardiotomy

    Refractory sustainedtachyarrhythmias

    Acute fulminant myocarditis

    End-stagecardiomyopathyHypertrophiccardiomyopathy with severeoutflow obstruction

    Aortic dissection with aorticinsufficiency or tamponade

    Pulmonary embolu

    Severe valvular heart disease -Critical aortic or mitral stenosis,Acute severe aortic or MR

  • 5/19/2018 Cardiogenic_Shock.ppt

    11/27

    Pathophysiology

  • 5/19/2018 Cardiogenic_Shock.ppt

    12/27

    Clinical Findings

    Physical Exam: elevated JVP, +S3, rales,oliguria, acute pulmonary edema

    Hemodynamics: dec CO, inc SVR, decSvO2

    Initial evaluation: hemodynamics (PAcatheter), echocardiography, angiography

  • 5/19/2018 Cardiogenic_Shock.ppt

    13/27

    4 Potential Therapies

    Pressors

    Intra-aortic Balloon Pump (IABP) Fibrinolytics

    Revascularization: CABG/PCI

    Refractory shock: ventricular assist device,

    cardiac transplantation

  • 5/19/2018 Cardiogenic_Shock.ppt

    14/27

    Pressors do not change outcome

    Dopamine

  • 5/19/2018 Cardiogenic_Shock.ppt

    15/27

    IABP is a temporizing measure

    Augments coronary blood flow in diastole

    Balloon collapse in systole creates a vacuum

    effectdecreases afterload

    Decrease myocardial oxygen demand

  • 5/19/2018 Cardiogenic_Shock.ppt

    16/27

    Indication for IABP

  • 5/19/2018 Cardiogenic_Shock.ppt

    17/27

    Contraindications to IABP

    Significant aortic regurgitation or significant

    arteriovenous shunting

    Abdominal aortic aneurysm or aortic dissection

    Uncontrolled sepsis

    Uncontrolled bleeding disorder

    Severe bilateral peripheral vascular disease Bilateral femoral popliteal bypass grafts for severe

    peripheral vascular disease.

  • 5/19/2018 Cardiogenic_Shock.ppt

    18/27

    Complications of IABP

    Cholesterol Embolization

    CVA Sepsis

    Balloon rupture

    Thrombocytopenia Hemolysis

    Groin Infection

    Peripheral Neuropathy

  • 5/19/2018 Cardiogenic_Shock.ppt

    19/27

    Revascularization

    SHOCK trial

    Overall 30-Day Survival in the Study

    Hochman J et al. N Engl J Med 1999;341:625-634

  • 5/19/2018 Cardiogenic_Shock.ppt

    20/27

    SHOCK trial

    Hochman J et al. N Engl J Med 1999;341:625-634

  • 5/19/2018 Cardiogenic_Shock.ppt

    21/27

    Copyright restrictions may apply.

    Hochman, J. S. et al. JAMA 2006;295:2511-2515.

    Kaplan-Meier Long-term Survival of All Patients and Those Discharged Alive FollowingHospitalization

    SHOCK 6 years later

  • 5/19/2018 Cardiogenic_Shock.ppt

    22/27

    Question 1

  • 5/19/2018 Cardiogenic_Shock.ppt

    23/27

    Answer

  • 5/19/2018 Cardiogenic_Shock.ppt

    24/27

    Question 2

  • 5/19/2018 Cardiogenic_Shock.ppt

    25/27

    Answer

  • 5/19/2018 Cardiogenic_Shock.ppt

    26/27

    Question 3

  • 5/19/2018 Cardiogenic_Shock.ppt

    27/27

    Answer